Memória organizacional em apoio às decisões em uma empresa do setor tecnológico

Aborda a memória organizacional, como processo da Inteligência Organizacional, de modo a identificar como essa pode otimizar a tomada de decisão. O enfoque informacional é o de recuperação da informação vinculada aos processos, instruções de trabalho, ferramentas e técnicas da organização. A pesquisa busca responder se a empresa possui memória organizacional, com foco na recuperação da informação, de forma a otimizar o processo de tomada de decisão. A pesquisa, caracterizada como qualitativa e descritiva, com suporte da literatura sobre o tema, foi aplicada a uma empresa do setor tecnológico. O resultado apontou que a empresa tem políticas que visam dar suporte à incorporação dos processos e a melhorias contínuas ao usar experiências que permitem incrementar o acervo de informações e conhecimentos da organização. Contudo, possuí deficiências quanto à recuperação da informação, impactando negativamente o processo de tomada de decisão. O estudo propõe atenção às deficiências na recuperação de ativos de informação registrados na memória, em um contexto de inteligência organizacional

Ocular biometry of snakes of the species Python bivittatus kept in captivity

During embryological development, the eyelids of snakes fuse and no longer open like in mammals. They become transparent, thus forming spectacles, a transparent structure that covers the eyes. The primary function of these spectacles is to provide a physical barrier to protect the eyes without eyelids. This study aimed to evaluate the ocular biometry of Python bivittatus snakes. Ocular ultrasound examinations were performed on four individuals using the Logic E ultrasound device (GE, United States) with a 10-22 MHz linear probe. Conduction gel was used to make transducer contact with the cornea in these snakes. Images were obtained to evaluate the following measurements: axial length of the eyeball, anterior chamber depth, lens thickness, and vitreous depth. These measurements of intraocular structures were, respectively: 0.05 ± 0.02 cm for corneal thickness in the right eye and 0.04 ± 0.007 cm in the left eye; 0.11 ± 0.04 cm for anterior chamber depth in the right and left eyes; 0.36 ± 0.07 cm for the lens thickness in the right eye and 0.39 ± 0.05 cm in the left eye; 0.35 ± 0.05 for the depth of the vitreous chamber in the right eye and 0.31 ± 0.02 cm in the left eye; and 0.85 ± 0.18 cm for the length of the globe in the axial plane in the right eye and 0.85 ± 0.14 cm in the left eye. Knowledge of snakes’ anatomical and ophthalmological parameters is scarce, and the incidence of eye diseases is still little known, making further studies necessary.Durante o desenvolvimento embriológico as pálpebras das cobras se fundem e não reabrem mais como nos mamíferos, elas se tornam transparentes formando uma escama ocular, uma estrutura transparente que cobre os olhos. A escama ocular tem como principal função fornecer uma barreira física para proteger o olho na ausência de pálpebras. O objetivo desse trabalho foi avaliar a biometria ocular das serpentes Python bivittatus. O exame ultrassonográfico ocular foi realizado com um aparelho de ultrassom Logic E, GE, Estados Unidos, com sonda linear 10-22 MHz, utilizou-se gel de condução para realizar o contato do transdutor com a córnea dos 4 animais avaliados. As medidas avaliadas foram a profundidade da câmara anterior, espessura da lente, a profundidade do vítreo e o comprimento axial do globo ocular. Foram realizadas imagens obtendo as medidas do comprimento axial do globo ocular, câmara anterior, espessura da lente e a profundidade do vítreo. As estruturas intraoculares medidas foram, respectivamente: 0,05 ± 0,02 cm para espessura da córnea no olho direito e 0,04 ± 0,007 cm no olho esquerdo, 0,11 ± 0,04 cm para a profundidade da câmara anterior nos olhos direito e esquerdo, 0,36 ± 0,07 cm para a espessura da lente do olho direito e 0,39 ± 0,05 cm do olho esquerdo, 0,35 ± 0,05 para a profundidade da câmara vítrea no olho direito e 0,31 ± 0,02 cm no olho esquerdo e 0,85 ± 0,18 cm para o comprimento do globo no plano axial no olho direito e 0,85 ± 0,14 cm no olho esquerdo. O conhecimento dos parâmetros anatômicos e oftalmológicos das serpentes é escasso e a incidência de doenças oculares ainda é pouco conhecida, o que torna necessário mais estudos relacionados ao tema

Greater Weight Gain in Treatment-naive Persons Starting Dolutegravir-based Antiretroviral Therapy

Background Recent studies have reported weight gain in virologically suppressed persons living with human immunodeficiency virus (PLWH) switched from older antiretroviral therapy (ART) to newer integrase strand transfer inhibitor (INSTI)–based regimens. In this study, we investigated whether weight gain differs among treatment-naive PLWH starting INSTI-based regimens compared to other ART regimens. Methods Adult, treatment-naive PLWH in the Vanderbilt Comprehensive Care Clinic cohort initiating INSTI-, protease inhibitor (PI)–, and nonnucleoside reverse transcriptase inhibitor (NNRTI)–based ART between January 2007 and June 2016 were included. We used multivariable linear mixed-effects models to generate marginal predictions of weights over time, adjusting for baseline clinical and demographic characteristics. We used restricted cubic splines to relax linearity assumptions and bootstrapping to generate 95% confidence intervals. Results Among 1152 ART-naive PLWH, 351 initiated INSTI-based regimens (135 dolutegravir, 153 elvitegravir, and 63 raltegravir), 86% were male, and 49% were white. At ART initiation, median age was 35 years, body mass index was 25.1 kg/m2, and CD4+ T-cell count was 318 cells/μL. Virologic suppression at 18 months was similar between different ART classes. At all examined study time points, weight gain was highest among PLWH starting dolutegravir. At 18 months, PLWH on dolutegravir gained 6.0 kg, compared to 2.6 kg for NNRTIs (P < .05), and 0.5 kg for elvitegravir (P < .05). PLWH starting dolutegravir also gained more weight at 18 months compared to raltegravir (3.4 kg) and PIs (4.1 kg), though these differences were not statistically significant. Conclusions Treatment-naive PLWH starting dolutegravir-based regimens gained significantly more weight at 18 months than those starting NNRTI-based and elvitegravir-based regimens

Mortalidade hospitalar por covid-19 em crianças e adolescentes no Brasil em 2020–2021

OBJECTIVE: To describe cases, deaths, and hospital mortality from covid-19 in children andadolescents in Brazil, according to age group, during the evolving phases of the pandemic in2020 and 2021.METHODS: Census of patients aged up to 19 committed with severe acute respiratory syndrome, due to covid-19 or unspecified, notified to the Brazilian Influenza Epidemiological Surveillance Information System, from January 1, 2020, to December 31, 2021. The two years were divided into six phases, covering the spread of the disease—first, second and third wave—as well as the impact of vaccination. The pediatric population was categorized into infants, preschoolers, schoolchildren, and adolescents. Hospital mortality was assessed by pandemic phase and age group.RESULTS: A total of 144,041 patients were recorded in the two years, 18.2% of whom had confirmed cases of covid-19. Children under 5 years old (infants and preschoolers) accounted for 62.8% of those hospitalized. A total of 4,471 patients died, representing about 6.1 deaths per day. Infants were the ones who most progressed to the intensive care unit (24.7%) and had the highest gross number of deaths (n = 2,012), but mortality was higher among adolescents (5.7%), reaching 9.8% in phase 1. The first peak of deaths occurred in phase 1 (May/2020), and two other peaks occurred in phase 4 (March/2021 and May/2021). There was an increase in cases and deaths for younger ages since phase 4. Hospital mortality in the pediatric population washigher in phases 1, 4, and 6, following the phenomena of dissemination/interiorization of thevirus in the country, beginning of the second wave and beginning of the third wave, respectively.CONCLUSION: The absolute number of cases o f covid-19 in children and adolescents is significant. Although complete vaccination in descending order of age provided a natural deviation in age range, there was a greater gap between the curve of new hospitalized cases and the curve of deaths, indicating the positive impact of immunization.OBJETIVO: Descrever casos, óbitos e mortalidade hospitalar por covid-19 em crianças e adolescentes no Brasil, conforme faixa etária, durante as fases de evolução da pandemia em 2020 e 2021. MÉTODOS: Censo de pacientes de até 19 anos internados com síndrome respiratória aguda grave, por covid-19 ou não especificada, notificados ao Sistema de Informação de Vigilância Epidemiológica da Gripe do Brasil, entre 1 de janeiro de 2020 e 31 de dezembro de 2021. Os dois anos foram divididos em seis fases, abrangendo a disseminação da doença − primeira, segunda e terceira onda −, bem como o impacto da vacinação. A população pediátrica foi categorizada em lactentes, pré-escolares, escolares e adolescentes. A mortalidade hospitalar foi avaliada por fase da pandemia e faixa etária. RESULTADOS: Foram contabilizados 144.041 pacientes nos dois anos, sendo 18,2% casos de covid-19 confirmados. Menores de 5 anos (lactentes e pré-escolares) corresponderam a 62,8% dos hospitalizados. Evoluíram a óbito 4.471, representando cerca 6,1 óbitos por dia. Os lactentes foram os que mais evoluíram para unidade de terapia intensiva (24,7%) e apresentaram o maior número bruto de óbito (n = 2.012), porém a mortalidade foi maior entre os adolescentes (5,7%), chegando a 9,8% na fase 1. O primeiro pico de óbitos ocorreu na fase 1 (maio/2020), e outros dois picos ocorreram na fase 4 (março/2021 e maio/2021). Verificou-se avanço de casos e óbitos para as idades inferiores desde a fase 4. A mortalidade hospitalar na população pediátrica foi maior nas fases 1, 4 e 6, acompanhando os fenômenos de disseminação/interiorização do vírus no país, início da segunda onda e início da terceira onda, respectivamente. CONCLUSÃO: O número absoluto de casos de covid-19 em crianças e adolescentes é expressivo. Embora a vacinação completa em ordem decrescente de idade tenha proporcionado um desvio natural de faixa etária, ocorreu um distanciamento maior entre a curva de novos casos hospitalizados e a curva de óbitos, indicando o impacto positivo da imunização

All-cause hospitalisation among people living with HIV according to gender, mode of HIV acquisition, ethnicity, and geographical origin in Europe and North America: findings from the ART-CC cohort collaboration

BACKGROUND: Understanding demographic disparities in hospitalisation is crucial for the identification of vulnerable populations, interventions, and resource planning. METHODS: Data were from the Antiretroviral Therapy Cohort Collaboration (ART-CC) on people living with HIV in Europe and North America, followed up between January, 2007 and December, 2020. We investigated differences in all-cause hospitalisation according to gender and mode of HIV acquisition, ethnicity, and combined geographical origin and ethnicity, in people living with HIV on modern combination antiretroviral therapy (cART). Analyses were performed separately for European and North American cohorts. Hospitalisation rates were assessed using negative binomial multilevel regression, adjusted for age, time since cART intitiaion, and calendar year. FINDINGS: Among 23 594 people living with HIV in Europe and 9612 in North America, hospitalisation rates per 100 person-years were 16·2 (95% CI 16·0-16·4) and 13·1 (12·8-13·5). Compared with gay, bisexual, and other men who have sex with men, rates were higher for heterosexual men and women, and much higher for men and women who acquired HIV through injection drug use (adjusted incidence rate ratios ranged from 1·2 to 2·5 in Europe and from 1·2 to 3·3 in North America). In both regions, individuals with geographical origin other than the region of study generally had lower hospitalisation rates compared with those with geographical origin of the study country. In North America, Indigenous people and Black or African American individuals had higher rates than White individuals (adjusted incidence rate ratios 1·9 and 1·2), whereas Asian and Hispanic people living with HIV had somewhat lower rates. In Europe there was a lower rate in Asian individuals compared with White individuals. INTERPRETATION: Substantial disparities exist in all-cause hospitalisation between demographic groups of people living with HIV in the current cART era in high-income settings, highlighting the need for targeted support. FUNDING: Royal Free Charity and the National Institute on Alcohol Abuse and Alcoholism

EFEITOS DA IMERSÃO EM ÁGUA FRIA NA RECUPERAÇÃO DE ÍNDICES ESPECTRAIS DA VARIABILIDADE DA FREQUÊNCIA CARDÍACA PÓS-EXERCÍCIO

A imersão em água fria (IAF) aparece no âmbito esportivo como estratégia para recuperar danos causados pelo estresse físico do exercício. Assim, analisar desfechos na aplicação desta técnica e suas variáveis sobre o efeito da Variabilidade da Frequência Cardíaca (VFC) parece pertinente. A metodologia do estudo consistiu no total de 100 participantes alocados em cinco grupos: GC: grupo controle; e grupos de intervenção por meio de imersão em água fria (IAF): G1: 5 min à 9 ± 1oC; G2: 5 min à 14 ± 1oC; G3: 15 min à 9 ± 1oC, G4: 15min à 14 ± 1oC. Após a captação da VFC basal, os participantes realizaram um protocolo de saltos e um teste de Wingate, seguidos da IAF. No índice VLF houve diferença estatística entre momentos de até 17 e 20 min e nos momentos T17 e T20 entre os grupos. Nos índices LF e HF houve diferença estatisticamente significante nos momentos de até 17, 20 e 40 min após exercício e entre os grupos no momento T20. Conclui-se que a IAF na avaliação da variabilidade global antecipa a recuperação entre 10 e 20 min comparado ao grupo controle

Tissue-specific melt electrowritten polymeric scaffolds for coordinated regeneration of soft and hard periodontal tissues

Periodontitis is a chronic inflammatory condition that often causes serious damage to tooth-supporting tissues. The limited successful outcomes of clinically available approaches underscore the need for therapeutics that cannot only provide structural guidance to cells but can also modulate the local immune response. Here, three-dimensional melt electrowritten ( i.e., poly(ε-caprolactone)) scaffolds with tissue-specific attributes were engineered to guide differentiation of human-derived periodontal ligament stem cells (hPDLSCs) and mediate macrophage polarization. The investigated tissue-specific scaffold attributes comprised fiber morphology (aligned vs. random) and highly-ordered architectures with distinct strand spacings (small 250 μm and large 500 μm). Macrophages exhibited an elongated morphology in aligned and highly-ordered scaffolds, while maintaining their round-shape on randomly-oriented fibrous scaffolds. Expressions of periostin and IL-10 were more pronounced on the aligned and highly-ordered scaffolds. While hPDLSCs on the scaffolds with 500 μm strand spacing show higher expression of osteogenic marker (Runx2) over 21 days, cells on randomly-oriented fibrous scaffolds showed upregulation of M1 markers. In an orthotopic mandibular fenestration defect model, findings revealed that the tissue-specific scaffolds ( i.e., aligned fibers for periodontal ligament and highly-ordered 500 μm strand spacing fluorinated calcium phosphate [F/CaP]-coated fibers for bone) could enhance the mimicking of regeneration of natural periodontal tissues

HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers

Background: It is unclear whether immunosuppression leads to younger ages at cancer diagnosis among people living with human immunodeficiency virus (PLWH). A previous study found that most cancers are not diagnosed at a younger age in people with AIDS, with the exception of anal and lung cancers. This study extends prior work to include all PLWH and examines associations between AIDS, CD4 count, and age at cancer diagnosis. Methods: We compared the median age at cancer diagnosis between PLWH in the North American AIDS Cohort Collaboration on Research and Design and the general population using data from the Surveillance, Epidemiology and End Results Program. We used statistical weights to adjust for population differences. We also compared median age at cancer diagnosis by AIDS status and CD4 count. Results: After adjusting for population differences, younger ages at diagnosis (P < .05) were observed for PLWH compared with the general population for lung (difference in medians = 4 years), anal (difference = 4), oral cavity/pharynx (difference = 2), and kidney cancers (difference = 2) and myeloma (difference = 4). Among PLWH, having an AIDS-defining event was associated with a younger age at myeloma diagnosis (difference = 4; P = .01), and CD4 count <200 cells/µL (vs ≥500) was associated with a younger age at lung cancer diagnosis (difference = 4; P = .006). Conclusions: Among PLWH, most cancers are not diagnosed at younger ages. However, this study strengthens evidence that lung cancer, anal cancer, and myeloma are diagnosed at modestly younger ages, and also shows younger ages at diagnosis of oral cavity/pharynx and kidney cancers, possibly reflecting accelerated cancer progression, etiologic heterogeneity, or risk factor exposure in PLWH